METHOTREXATE REDUCED TNF BIOACTIVITY BY ANTI-INFLIXIMAB ANTIBODY PREVENTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB

被引：0
|
作者：
Denarie, D. [1 ]
Rinaudo, M. [2 ]
Thomas, T. [1 ]
Paul, S. [2 ]
Marotte, H. [1 ]
机构：
[1] Chu St Etienne France, Rheumatol Unit, St Etienne, France
[2] Chu St Etienne France, Immunol & Immunomonitoring Dept, St Etienne, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3296
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0109
引用
收藏
页码：459 / 459
页数：1
相关论文
共 50 条
  • [41] An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status
    Arie E. van der Bijl
    Ferdinand C. Breedveld
    Christian E. Antoni
    Joachim R. Kalden
    Sonja Kary
    Gerd R. Burmester
    Christina Beckmann
    Kristina Unnebrink
    Hartmut Kupper
    Clinical Rheumatology, 2008, 27 : 1021 - 1028
  • [42] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    PEDIATRIC RESEARCH, 2011, 69 (03) : 243 - 248
  • [43] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Miha Kosmač
    Tadej Avčin
    Nataša Toplak
    Gabriele Simonini
    Rolando Cimaz
    Vladka Čurin Šerbec
    Pediatric Research, 2011, 69 : 243 - 248
  • [44] Clinical efficacy of infliximab level and anti-infliximab antibody measurement in patients with inflammatory bowel disease: An audit
    Dave, Mihika B.
    Dherai, Alpa J.
    Desai, Devendra C.
    Keny, Bhamini G.
    Shetty, Dhanashri N.
    Kulkarni, Satish
    Peddy, Kiran
    Ashavaid, Tester F.
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2020, 39 (05) : 426 - 434
  • [45] Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab
    D'Alessandro, Giuseppe
    Bianco, Maria Rosaria
    Politis, Spiridion
    Ferrandina, Celestino
    Rossi, Giuseppe
    Altomare, Emanuele
    REUMATISMO, 2006, 58 (01) : 59 - 61
  • [46] Infliximab (anti-TNF-alpha antibody) could improve insulin resistance in rheumatoid arthritis patients.
    Dobashi, H
    Kittaka, K
    Tokuda, M
    Oonishi, I
    Inoo, M
    Ishida, T
    Kurata, N
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S377 - S377
  • [47] Clinical efficacy of infliximab level and anti-infliximab antibody measurement in patients with inflammatory bowel disease: An audit
    Mihika B. Dave
    Alpa J. Dherai
    Devendra C. Desai
    Bhamini G. Keny
    Dhanashri N. Shetty
    Satish Kulkarni
    Kiran Peddy
    Tester F. Ashavaid
    Indian Journal of Gastroenterology, 2020, 39 : 426 - 434
  • [48] Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis
    van der Bijl, A. E.
    Goekoop-Ruiterman, Y. P. M.
    de Vries-Bouwstra, J. K.
    ten Wolde, S.
    Han, K. H.
    van Krugten, M. V.
    Allaart, C. F.
    Breedveld, F. C.
    Dijkmans, B. A. C.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (07): : 2129 - 2134
  • [49] The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure
    Krintel, Sophine B.
    Grunert, Veit Peter
    Hetland, Merete L.
    Johansen, Julia S.
    Rothfuss, Matthias
    Palermo, Giuseppe
    Essioux, Laurent
    Klause, Ursula
    RHEUMATOLOGY, 2013, 52 (07) : 1245 - 1253
  • [50] Visual evoked potentials (VEPS) in patients with rheumatoid arthritis treated with anti-TNF alpha antagonist infliximab
    Kotyla, PJ
    Lewicki, M
    Bal, A
    Sliwinska-Kotyla, B
    Kotulska, AT
    Kucharz, EJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 420 - 420
12345